DESTINY TRIAL (Inspiron x Biomatrix)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 170 participants.
Also called NCT01856088
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 170 participants
- Sponsor
- Registry
-
NCT01856088
-
- Other papers using this trial's data
- Metallic Limus-Eluting Stents Abluminally Coated with Biodegradable Polymers: Angiographic and Clinical Comparison of a Novel Ultra-Thin Sirolimus Stent Versus Biolimus Stent in the DESTINY Randomized Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Brazil
- Registry status
- Completed
Technical summary
Registry record NCT01856088. Randomized; no masking; primary purpose treatment. Start 2013-05 (actual); primary completion 2014-09 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- DESTINY TRIAL (Inspiron x Biomatrix)
- Condition
- Coronary Artery Disease
- Intervention (Device)
- Inspiron Stent
- Intervention (Device)
- Biomatrix Flex Stent
- Lead sponsor
- Scitech Produtos Medicos SA
Record details
- Record id
cardio:ct-nct01856088- Content hash
011b49e6ab9f1a2e25013ac8d5f91edb51f745045f4e5b92fea49cec0283556f